Registro completo |
Provedor de dados: |
BJID
|
País: |
Brazil
|
Título: |
Dyslipidemia in AIDS patients on highly active antiretroviral therapy
|
Autores: |
Nery,Max Weyler
Martelli,Celina Maria Turchi
Turchi,Marília Dalva
|
Data: |
2011-04-01
|
Ano: |
2011
|
Palavras-chave: |
Prevalence
Dyslipidemia
HIV
AIDS
HAART
|
Resumo: |
Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, however it has been associated with metabolic abnormalities. This study estimated the prevalence of lipid abnormalities and related factors among patients on HAART. A cross-sectional study was conducted on adult patients, in central Brazil. Patients were interviewed, and blood obtained for lipids measurement. Dyslipidemia was defined as total cholesterol (TC) > 240 mg/dL, low-density lipoprotein (LDL) > 160 mg/dL, triglycerides (TG) > 200 and/or high-density lipoprotein (HDL) < 40 mg/dL. Multiple logistic regression analyses were performed (SPSS 13.0). One hundred and thirteen patients were recruited. Mean age was 39.3 years; 68.1% were males; 50.4% were on nucleoside reverse transcriptase inhibitors (NRTI) in combination with non-nucleoside reverse transcriptase inhibitors (NNRTI), while 42.5% were on NRTI in combination with protease inhibitors (PIs). The prevalence of dyslipidemia was 66.7%. Low HDL was the most frequent abnormality (53.5%), followed by high TG (36.1%). Patients on a PI regimen had a 5.2-fold higher risk (95% CI: 1.8-14.8) of dyslipidemia, even after adjusting for sex, age, and duration of HIV infection/AIDS. The study discloses a high prevalence rate of dyslipidemia and points out a need for intervention programs to reduce future cardiovascular events in patients, on HAART.
|
Tipo: |
Info:eu-repo/semantics/article
|
Idioma: |
Inglês
|
Identificador: |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702011000200010
|
Editor: |
Brazilian Society of Infectious Diseases
|
Relação: |
10.1590/S1413-86702011000200010
|
Formato: |
text/html
|
Fonte: |
Brazilian Journal of Infectious Diseases v.15 n.2 2011
|
Direitos: |
info:eu-repo/semantics/openAccess
|